Hikal P/B Ratio

HIKAL • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
2.3
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Current Valuation Metrics

P/B Ratio 2.3
Current Price ₹218.28
Book Value/Share ₹504.80
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹1,262 Cr
Share Capital ₹25 Cr
Reserves & Surplus ₹1,238 Cr
Outstanding Shares 25,000,000
Book Value per Share ₹504.80

Valuation Signal

Signal Fairly Valued
Historical Avg 0.86
Historical Range 0.45 - 1.41
Percentile 100.0%

Sector Context

Sector Average -0.1
Sector Median 0.66
Sector Rank #11 of 50
Sector Percentile 22.0%

Key P/B Ratio Insights for Hikal

  • Current PB is 166.8% above historical average
  • Trading at premium to sector average PB of -0.1

View the current stock price of Hikal for more insights.

P/B Ratio Historical Trend for Hikal

Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.

Historical P/B Ratio Data

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 0.45 ₹504.8 ₹226.83 ₹1,262 Low
2024 0.82 ₹475.2 ₹390.50 ₹1,188 Low
2023 0.67 ₹453.6 ₹303.95 ₹1,134 Low
2022 0.96 ₹427.2 ₹410.10 ₹1,068 Low
2021 1.41 ₹373.2 ₹526.75 ₹933 Moderate

Sector P/B Ratio Comparison

Comparing Hikal with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -12.97 ₹4,391 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Triochem Products TRIPR 0.04 ₹0 Low
Murae Organisor MURAE 0.26 ₹55 Low